Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps.

MLA

Tanzini, Umberto, et al. “Dupilumab: A Delayed Response in Asthmatic and Atopic Patients Treated for Chronic Rhinosinusitis with Nasal Polyps.” European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, vol. 281, no. 10, Oct. 2024, pp. 5285–92. EBSCOhost, https://doi.org/10.1007/s00405-024-08738-2.

APA

Tanzini, U., Rampi, A., Vinciguerra, A., Danè, G., Yacoub, M. R., Bussi, M., & Trimarchi, M. (2024). Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 281(10), 5285–5292. https://doi.org/10.1007/s00405-024-08738-2

Chicago

Tanzini, Umberto, Andrea Rampi, Alessandro Vinciguerra, Giulia Danè, Mona Rita Yacoub, Mario Bussi, and Matteo Trimarchi. 2024. “Dupilumab: A Delayed Response in Asthmatic and Atopic Patients Treated for Chronic Rhinosinusitis with Nasal Polyps.” European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 281 (10): 5285–92. doi:10.1007/s00405-024-08738-2.